Search research articles
Contact Us
Filters
Showing results (141-150 of 184) with videos related to
Page
of 19
Sort By:
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
October 30, 2016
The association of financial difficulties with clinical outcomes in cancer patients: secondary analysis of 16 academic prospective clinical trials conducted in Italy
F Perrone, C Jommi, M Di Maio, et al.
ESMO Open
|
December 1, 2024
Corrigendum to "Under-reporting of subjective symptoms and its prognostic value: a pooled analysis of 12 cancer clinical trials": [ESMO Open 9 (2024) 102941]
L Arenare, R Di Liello, P De Placido, et al.
British Journal of Cancer
|
November 24, 2004
A randomised clinical trial of two docetaxel regimens (weekly vs 3 week) in the second-line treatment of non-small-cell lung cancer. The DISTAL 01 study
C Gridelli, C Gallo, M Di Maio, et al.
Cancer Treatment Reviews
|
January 13, 2023
Optimizing choices and sequences in the diagnostic-therapeutic landscape of advanced triple-negative breast cancer: An Italian consensus paper and critical review
F Miglietta, A Fabi, D Generali, et al.
Cancer Treatment Reviews
|
July 3, 2023
Corrigendum to "Optimizing choices and sequences in the diagnostic-therapeutic landscape of advanced triple-negative breast cancer: An Italian consensus paper and critical review" [Cancer Treat. Rev. 114 (2023) 102511]
F Miglietta, A Fabi, D Generali, et al.
Cancer Treatment Reviews
|
May 7, 2023
Corrigendum to "Optimizing choices and sequences in the diagnostic-therapeutic landscape of advanced triple-negative breast cancer: An Italian consensus paper and critical review" [Cancer Treatm. Rev. 114 (2023) 102511]
F Miglietta, A Fabi, D Generali, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
October 1, 1996
Mitomycin C plus vindesine plus etoposide (MEV) versus mitomycin C plus vindesine plus cisplatin (MVP) in stage IV non-small-cell lung cancer: A phase III multicentre randomised trial. The "Gruppo Oncologico Centro-Sud-Isole' (G.O.C.S.I.)
C Gridelli, F Perrone, S Palmeri, et al.
Cancer Immunology, Immunotherapy : CII
|
April 17, 2025
Association of peripheral monocytic myeloid-derived suppressor cells with molecular subtypes in single-center endometrial cancer patients receiving carboplatin + paclitaxel/avelumab (MITO-END3 trial)
C D'Alterio, G Rea, M Napolitano, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
July 9, 2015
BRAF codons 594 and 596 mutations identify a new molecular subtype of metastatic colorectal cancer at favorable prognosis
C Cremolini, M Di Bartolomeo, A Amatu, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
August 10, 2016
Toward the molecular dissection of peritoneal pseudomyxoma
F Pietrantonio, F Perrone, A Mennitto, et al.
Page
of 19
Search research articles
Search
Showing results (141-150 of 184) with videos related to
Sort By:
Page
of 19
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
October 30, 2016
The association of financial difficulties with clinical outcomes in cancer patients: secondary analysis of 16 academic prospective clinical trials conducted in Italy
F Perrone, C Jommi, M Di Maio, et al.
ESMO Open
|
December 1, 2024
Corrigendum to "Under-reporting of subjective symptoms and its prognostic value: a pooled analysis of 12 cancer clinical trials": [ESMO Open 9 (2024) 102941]
L Arenare, R Di Liello, P De Placido, et al.
British Journal of Cancer
|
November 24, 2004
A randomised clinical trial of two docetaxel regimens (weekly vs 3 week) in the second-line treatment of non-small-cell lung cancer. The DISTAL 01 study
C Gridelli, C Gallo, M Di Maio, et al.
Cancer Treatment Reviews
|
January 13, 2023
Optimizing choices and sequences in the diagnostic-therapeutic landscape of advanced triple-negative breast cancer: An Italian consensus paper and critical review
F Miglietta, A Fabi, D Generali, et al.
Cancer Treatment Reviews
|
July 3, 2023
Corrigendum to "Optimizing choices and sequences in the diagnostic-therapeutic landscape of advanced triple-negative breast cancer: An Italian consensus paper and critical review" [Cancer Treat. Rev. 114 (2023) 102511]
F Miglietta, A Fabi, D Generali, et al.
Cancer Treatment Reviews
|
May 7, 2023
Corrigendum to "Optimizing choices and sequences in the diagnostic-therapeutic landscape of advanced triple-negative breast cancer: An Italian consensus paper and critical review" [Cancer Treatm. Rev. 114 (2023) 102511]
F Miglietta, A Fabi, D Generali, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
October 1, 1996
Mitomycin C plus vindesine plus etoposide (MEV) versus mitomycin C plus vindesine plus cisplatin (MVP) in stage IV non-small-cell lung cancer: A phase III multicentre randomised trial. The "Gruppo Oncologico Centro-Sud-Isole' (G.O.C.S.I.)
C Gridelli, F Perrone, S Palmeri, et al.
Cancer Immunology, Immunotherapy : CII
|
April 17, 2025
Association of peripheral monocytic myeloid-derived suppressor cells with molecular subtypes in single-center endometrial cancer patients receiving carboplatin + paclitaxel/avelumab (MITO-END3 trial)
C D'Alterio, G Rea, M Napolitano, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
July 9, 2015
BRAF codons 594 and 596 mutations identify a new molecular subtype of metastatic colorectal cancer at favorable prognosis
C Cremolini, M Di Bartolomeo, A Amatu, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
August 10, 2016
Toward the molecular dissection of peritoneal pseudomyxoma
F Pietrantonio, F Perrone, A Mennitto, et al.
Page
of 19